What is Ironwood Pharmaceuticals's return on equity?

Ironwood Pharmaceuticals (IRWD) reported return on equity of 29.7% in Q1 2023.

How has Ironwood Pharmaceuticals's return on equity changed year-over-year?

Ironwood Pharmaceuticals's return on equity decreased by 82.3% year-over-year, from 167.9% to 29.7%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Ironwood Pharmaceuticals IRWD Return on equity

Discontinued — last reported Q1 '23

Return on equity at other companies

ArdelyxARDX

-39.5%—

Eton Pharmaceuticals, Inc.ETON

-34.2%+0.9pp

Rigel PharmaceuticalsRIGL

174.1%—

ANI PharmaceuticalsANIP

18.8%+15.6pp

Catalyst PharmaceuticalCPRX

24.5%-4.6pp

Lexicon PharmaceuticalsLXRX

-16%-7.2pp

Other financials

Income statement

See full

Revenue$106.5M+159%

Operating income$72.6M+349%

Net income$40.8M+209%

EPS (diluted)$0.24+204%

Balance sheet

See full

Cash & equivalents$220.5M+103%

Total debt$212.4M+1,323%

Total equity-$217.1M+35.0%

Total assets$434.6M+32.8%

Cash flow

See full

Operating cash flow$5.1M-74.3%

CapEx-—

Free cash flow$74.6M+390%

Valuation

See full

Market cap$632.12M+457%

Enterprise value$624M+3,024%

P/E6.2×—

P/S1.8×+1.4×

Profitability

See full

Gross margin99.2%—

Operating margin55.4%+38.7pp

Net margin28.3%+22.3pp

FCF margin24.7%-11.1pp

Returns & leverage

See full

Debt / equity0×-0.5×

Current ratio1.4×-1.9×

Where this comes from

Calculated from Ironwood Pharmaceuticals’s reported figures.

net income/total stockholders equity=29.7%

Based on trailing twelve months.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 9, 2024, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ironwood Pharmaceuticals's return on equity?: Ironwood Pharmaceuticals (IRWD) reported return on equity of 29.7% in Q1 2023.
How has Ironwood Pharmaceuticals's return on equity changed year-over-year?: Ironwood Pharmaceuticals's return on equity decreased by 82.3% year-over-year, from 167.9% to 29.7%.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.